Immune responses of mice with different genetic backgrounds to improved multiepitope, multitarget malaria vaccine candidate antigen FALVAC-1A.

PubWeight™: 0.79‹?›

🔗 View Article (PMC 2583527)

Published in Clin Vaccine Immunol on September 10, 2008

Authors

S A Kaba1, A Price, Z Zhou, V Sundaram, P Schnake, I F Goldman, A A Lal, V Udhayakumar, C W Todd

Author Affiliations

1: Division of Parasitic Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA.

Articles cited by this

Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature (2008) 9.16

DNAWorks: an automated method for designing oligonucleotides for PCR-based gene synthesis. Nucleic Acids Res (2002) 5.75

Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J Exp Med (2008) 5.42

Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3. J Immunol (2008) 4.60

The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice. J Immunol Methods (1998) 2.78

Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells. J Immunol (1997) 2.43

Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid. Int Immunol (2003) 2.02

Genetic regulation of protective immune response in congenic strains of mice vaccinated with a subunit malaria vaccine. J Immunol (1996) 1.60

Development and regulation of cell-mediated immune responses to the blood stages of malaria: implications for vaccine research. Annu Rev Immunol (2005) 1.53

Protection induced by Plasmodium falciparum MSP1(42) is strain-specific, antigen and adjuvant dependent, and correlates with antibody responses. PLoS One (2008) 1.47

Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines. Vaccine (2001) 1.38

The mouse Igh-1a and Igh-1b H chain constant regions are derived from two distinct isotypic genes. Immunogenetics (1989) 1.24

Defined flanking spacers and enhanced proteolysis is essential for eradication of established tumors by an epitope string DNA vaccine. J Immunol (2001) 1.24

CD28, Ox-40, LFA-1, and CD4 modulation of Th1/Th2 differentiation is directly dependent on the dose of antigen. J Immunol (2000) 1.23

Immunogenicity and in vitro protective efficacy of a recombinant multistage Plasmodium falciparum candidate vaccine. Proc Natl Acad Sci U S A (1999) 1.19

A rational strategy to design multiepitope immunogens based on multiple Th lymphocyte epitopes. J Immunol (2002) 1.19

Identification of novel immunodominant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity. J Virol (2003) 1.19

ELISPOT assay to measure antigen-specific murine CD8(+) T cell responses. J Immunol Methods (2001) 1.15

Linkage of exogenous T-cell epitopes to the 19-kilodalton region of Plasmodium yoelii merozoite surface protein 1 (MSP1(19)) can enhance protective immunity against malaria and modulate the immunoglobulin subclass response to MSP1(19). Infect Immun (2000) 1.12

Malaria: immune evasion by parasites. Int J Biochem Cell Biol (2005) 1.09

Induction of T helper type 1 and 2 responses to 19-kilodalton merozoite surface protein 1 in vaccinated healthy volunteers and adults naturally exposed to malaria. Infect Immun (2002) 1.02

4th meeting on Novel Adjuvants Currently in/close to Human Clinical Testing World Health Organization -- organisation Mondiale de la Santé Fondation Mérieux, Annecy, France, 23-25, June 2003. Vaccine (2004) 1.02

Antigen dose defines T helper 1 and T helper 2 responses in the lungs of C57BL/6 and BALB/c mice independently of splenic responses. Immunol Lett (2000) 0.98

Comparison of immunogenicities of recombinant Plasmodium vivax merozoite surface protein 1 19- and 42-kiloDalton fragments expressed in Escherichia coli. Infect Immun (2004) 0.98

Cytokines and antibody subclass associated with protective immunity against blood-stage malaria in mice vaccinated with the C terminus of merozoite surface protein 1 plus a novel adjuvant. Infect Immun (1996) 0.96

Immunogenicity of an alum-adsorbed synthetic multiple-antigen peptide based on B- and T-cell epitopes of the Plasmodium falciparum CS protein: possible vaccine application. Vaccine (1994) 0.92

Improved protection from primary ocular HSV-1 infection and establishment of latency using multigenic DNA vaccines. Invest Ophthalmol Vis Sci (2004) 0.89

Pathways for potentiation of immunogenicity during adjuvant-assisted immunizations with Plasmodium falciparum major merozoite surface protein 1. Infect Immun (1998) 0.84

Adjuvant activity of polymer microparticles and Montanide ISA 720 on immune responses to Plasmodium falciparum MSP2 long synthetic peptides in mice. Vaccine (2006) 0.83

Development, characterization and immunogenicity of a multi-stage, multi-valent Plasmodium falciparum vaccine antigen (FALVAC-1A) expressed in Escherichia coli. Hum Vaccin (2006) 0.83

Long-lasting protective immunity against rodent malaria parasite infection at the blood stage by recombinant BCG secreting merozoite surface protein-1. Vaccine (1999) 0.83

Influence of adjuvants in inducing immune responses to different epitopes included in a multiepitope, multivalent, multistage Plasmodium falciparum candidate vaccine (FALVAC-1) in outbred mice. Exp Parasitol (2002) 0.82

Synthetic peptide epitope-based polymers: controlling size and determining the efficiency of epitope incorporation. J Pept Res (2002) 0.82

Development, expression, and murine testing of a multistage Plasmodium falciparum malaria vaccine candidate. Vaccine (2000) 0.81

Vigorous hepatitis C virus-specific CD4+ and CD8+ T cell responses induced by protein immunization in the presence of Montanide ISA720 plus synthetic oligodeoxynucleotides containing immunostimulatory cytosine-guanine dinucleotide motifs. J Infect Dis (2006) 0.79

Do Th1 or Th2 sequence motifs exist in proteins? Identification of amphipatic immunomodulatory domains in Helicobacter pylori catalase. Immunol Lett (2005) 0.79

Design of synthetic peptidic constructs for the vaccine development against viral infections. Curr Protein Pept Sci (2004) 0.79

Adjuvants and malaria vaccine development. Chem Immunol (2002) 0.78

Differential antigenicity of recombinant polyepitope-antigens based on loop- and helix-forming B and T cell epitopes. J Immunol Methods (2000) 0.78

2nd meeting on novel adjuvants currently in/close to human clinical testing. World Health Organization-Organization Mondiale de la Santé Fondation Mérieux, Annecy, France, 5-7 June 2000. Vaccine (2002) 0.77

Immunogenicity of polyepitope libraries assembled by epitope shuffling: an approach to the development of chimeric gene vaccination against malaria. Vaccine (2004) 0.77

Immunomodulatory activity of novel adjuvant formulations based on Montanide ISA oil-based adjuvants and peptidoglycan monomer. Int Immunopharmacol (2008) 0.76

Articles by these authors

Osteopathic medicine: a call for reform. J Am Osteopath Assoc (1993) 7.79

Identification of 5 types of Cryptosporidium parasites in children in Lima, Peru. J Infect Dis (2000) 6.71

Phylogenetic analysis of Cryptosporidium parasites based on the small-subunit rRNA gene locus. Appl Environ Microbiol (1999) 5.57

The DNA replication and damage checkpoint pathways induce transcription by inhibition of the Crt1 repressor. Cell (1998) 5.37

The SAD1/RAD53 protein kinase controls multiple checkpoints and DNA damage-induced transcription in yeast. Genes Dev (1994) 5.20

DNA polymerase epsilon links the DNA replication machinery to the S phase checkpoint. Cell (1995) 4.90

Diagnostic risk adjustment for Medicaid: the disability payment system. Health Care Financ Rev (1996) 4.34

A Ypt/Rab effector complex containing the Sec1 homolog Vps33p is required for homotypic vacuole fusion. Proc Natl Acad Sci U S A (2000) 4.33

A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N Engl J Med (1995) 4.30

Genetic diversity within Cryptosporidium parvum and related Cryptosporidium species. Appl Environ Microbiol (1999) 4.22

Genetic polymorphism among Cryptosporidium parvum isolates: evidence of two distinct human transmission cycles. Emerg Infect Dis (1997) 4.02

Pre-mRNA splicing and mRNA export linked by direct interactions between UAP56 and Aly. Nature (2001) 3.94

Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut (1996) 3.94

The evolution of primate malaria parasites based on the gene encoding cytochrome b from the linear mitochondrial genome. Proc Natl Acad Sci U S A (1998) 3.93

Translocation (8;21) in oligoblastic leukemia: is this a true myelodysplastic syndrome? Leuk Res (1994) 3.66

Cloning and expression in Escherichia coli of the gene for human tumour necrosis factor. Nature (1985) 3.59

Improving surgical resection rate in lung cancer. Thorax (1998) 3.45

A low interleukin-10 tumor necrosis factor-alpha ratio is associated with malaria anemia in children residing in a holoendemic malaria region in western Kenya. J Infect Dis (1999) 3.26

A primitive enantiornithine bird and the origin of feathers. Science (2000) 2.96

Radioimmune assay of carcinoembryonic antigen. Immunochemistry (1972) 2.95

Identification of species and sources of Cryptosporidium oocysts in storm waters with a small-subunit rRNA-based diagnostic and genotyping tool. Appl Environ Microbiol (2000) 2.91

Differentiating human from animal isolates of Cryptosporidium parvum. Emerg Infect Dis (1999) 2.89

DNA damage and cell cycle regulation of ribonucleotide reductase. Bioessays (1993) 2.81

Fractional contribution of calcium to the cation current through glutamate receptor channels. Neuron (1993) 2.69

Risk of developing colorectal cancer and benign colorectal neoplasm in patients with chronic constipation. Aliment Pharmacol Ther (2014) 2.67

Fractional calcium currents through recombinant GluR channels of the NMDA, AMPA and kainate receptor subtypes. J Physiol (1995) 2.67

Drosophila dumbfounded: a myoblast attractant essential for fusion. Cell (2000) 2.65

The prevalence of nocturia and its effect on health-related quality of life and sleep in a community sample in the USA. BJU Int (2003) 2.59

Generation of single-nucleotide repair patches following excision of uracil residues from DNA. Mol Cell Biol (1992) 2.53

Primary sequences of two small subunit ribosomal RNA genes from Plasmodium falciparum. Mol Biochem Parasitol (1988) 2.48

Inducible T cell antigen 4-1BB. Analysis of expression and function. J Immunol (1993) 2.40

Differential effect of steady versus oscillating flow on bone cells. J Biomech (1998) 2.38

Identification of Plasmodium vivax-like human malaria parasite. Lancet (1993) 2.37

Genetic polymorphism and natural selection in the malaria parasite Plasmodium falciparum. Genetics (1998) 2.36

Cystic fibrosis gene mutations and pancreatitis risk: relation to epithelial ion transport and trypsin inhibitor gene mutations. Gastroenterology (2001) 2.36

Safety and biological efficacy of a lipid-CFTR complex for gene transfer in the nasal epithelium of adult patients with cystic fibrosis. Mol Ther (2000) 2.34

MAP kinase-related FUS3 from S. cerevisiae is activated by STE7 in vitro. Nature (1993) 2.33

A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kiloDalton domain of Plasmodium falciparum in pregnant women and infants: associations with febrile illness, parasitemia, and anemia. Am J Trop Med Hyg (1998) 2.33

The crisis in osteopathic medicine. Acad Med (1992) 2.32

Oxygen-bridged dinuclear ruthenium amine complex specifically inhibits Ca2+ uptake into mitochondria in vitro and in situ in single cardiac myocytes. J Biol Chem (1998) 2.32

Characterizing the phenomenon of radiation recall dermatitis. Radiother Oncol (2001) 2.31

Functional association of U2 snRNP with the ATP-independent spliceosomal complex E. Mol Cell (2000) 2.27

Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs (1988) 2.27

The smallest known non-avian theropod dinosaur. Nature (2000) 2.26

A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations. N Engl J Med (1994) 2.25

Vivax malaria resistant to treatment and prophylaxis with chloroquine. Lancet (1993) 2.23

Lessons from loricrin-deficient mice: compensatory mechanisms maintaining skin barrier function in the absence of a major cornified envelope protein. J Cell Biol (2000) 2.22

Function of the Escherichia coli msbB gene, a multicopy suppressor of htrB knockouts, in the acylation of lipid A. Acylation by MsbB follows laurate incorporation by HtrB. J Biol Chem (1997) 2.17

PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. J Control Release (2001) 2.15

Fibrosing colonopathy in an adult owing to over use of pancreatic enzyme supplements. Gut (2000) 2.10

Mechanism of block and identification of the verapamil binding domain to HERG potassium channels. Circ Res (1999) 2.10

Variation in Cryptosporidium: towards a taxonomic revision of the genus. Int J Parasitol (1999) 2.07

Ribonucleotide reductase: regulation, regulation, regulation. Trends Biochem Sci (1992) 2.07

C1 inhibitor deficiency: consensus document. Clin Exp Immunol (2005) 2.07

Factors influencing the care-seeking behaviour of chest symptomatics: a community-based study involving rural and urban population in Tamil Nadu, South India. Trop Med Int Health (2003) 2.07

Antigenic variation of a cysteine-rich protein in Giardia lamblia. J Exp Med (1988) 1.98

Polymorphism in the gene encoding the apical membrane antigen-1 (AMA-1) of Plasmodium falciparum. X. Asembo Bay Cohort Project. Mol Biochem Parasitol (2001) 1.96

Odontogenic tumors. A demographic study of 759 cases in a Chinese population. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1998) 1.93

The impact on health-related quality of life of stress, urge and mixed urinary incontinence. BJU Int (2003) 1.93

Wild primate populations in emerging infectious disease research: the missing link? Emerg Infect Dis (1998) 1.91

Occupational exposure to bisphenol-A (BPA) and the risk of self-reported male sexual dysfunction. Hum Reprod (2009) 1.87

A precision measurement of the mass of the top quark. Nature (2004) 1.87

Glycosylphosphatidylinositol anchors of Plasmodium falciparum: molecular characterization and naturally elicited antibody response that may provide immunity to malaria pathogenesis. J Exp Med (2000) 1.87

A comparison of Cryptosporidium subgenotypes from several geographic regions. J Eukaryot Microbiol (2001) 1.86

Making risk adjustment work for everyone. Inquiry (1995) 1.85

Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. Immunity (1997) 1.84

Sequence variation in putative functional domains of the circumsporozoite protein of Plasmodium falciparum. Implications for vaccine development. J Biol Chem (1987) 1.82

Pulmonary epithelial sodium-channel dysfunction and excess airway liquid in pseudohypoaldosteronism. N Engl J Med (1999) 1.81

SecYEG and SecA are the stoichiometric components of preprotein translocase. J Biol Chem (1995) 1.81

The Community Medical Alliance: an integrated system of care in Greater Boston for people with severe disability and AIDS. Manag Care Q (1996) 1.81

Identification of T and B cell epitopes recognized by humans in the C-terminal 42-kDa domain of the Plasmodium falciparum merozoite surface protein (MSP)-1. J Immunol (1995) 1.79

Rapid disease progression correlates with instability of mutant SOD1 in familial ALS. Neurology (2005) 1.78

Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1. Infect Immun (1996) 1.78

Translocation of C. elegans CED-4 to nuclear membranes during programmed cell death. Science (2000) 1.77

Phylogenetic relationships of Cryptosporidium parasites based on the 70-kilodalton heat shock protein (HSP70) gene. Appl Environ Microbiol (2000) 1.76

Breast cancer metastatic potential correlates with a breakdown in homospecific and heterospecific gap junctional intercellular communication. Cancer Res (2001) 1.72

Primary hip replacement prostheses and their evidence base: systematic review of literature. BMJ (2013) 1.69

Covalent regulation of ULVWF string formation and elongation on endothelial cells under flow conditions. J Thromb Haemost (2008) 1.68

Plasmodium falciparum genotypes, low complexity of infection, and resistance to subsequent malaria in participants in the Asembo Bay Cohort Project. Infect Immun (2001) 1.66

Cryptosporidium systematics and implications for public health. Parasitol Today (2000) 1.66

Sequence differences in the diagnostic target region of the oocyst wall protein gene of Cryptosporidium parasites. Appl Environ Microbiol (2000) 1.64

Observer variation and discriminatory value of biopsy features in inflammatory bowel disease. Gut (1994) 1.64

Mechanically stimulated osteocytes regulate osteoblastic activity via gap junctions. Am J Physiol Cell Physiol (2006) 1.63

Does reduced length of stay decrease the number of emergency department patients who leave without seeing a physician? J Emerg Med (1997) 1.63

A population genetic study of the Cryptosporidium parvum human genotype parasites. J Eukaryot Microbiol (2001) 1.63

Differential effect and interaction of monocytes, hyperimmune sera, and immunoglobulin G on the growth of asexual stage Plasmodium falciparum parasites. Am J Trop Med Hyg (1999) 1.62

Allotypy of rabbit immunoglobulin: an agglutinating specificity. Vox Sang (1968) 1.61

Symptom control and quality of life in people with lung cancer: a randomised trial of two palliative radiotherapy fractionation schedules. Clin Oncol (R Coll Radiol) (2005) 1.61

CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCR-5 usage. Virology (1998) 1.60

Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis. J Biol Chem (2001) 1.60

Disulfide bond reduction of von Willebrand factor by ADAMTS-13. J Thromb Haemost (2010) 1.59

Variants of the Ehlers-Danlos syndrome. Clinical, biochemical, haematological, and chromosomal features of 100 patients. Ann Rheum Dis (1969) 1.59

4-1BB T-cell antigen binds to mature B cells and macrophages, and costimulates anti-mu-primed splenic B cells. Eur J Immunol (1994) 1.58

Isolation and characterization of carcinoembryonic antigen. Immunochemistry (1972) 1.57